American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer.
about
Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?Video-Assisted versus Open Lobectomy in Patients with Compromised Lung Function: A Literature Review and Meta-AnalysisA critical review of recent developments in radiotherapy for non-small cell lung cancerRadiofrequency ablation for early-stage nonsmall cell lung cancer.Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.Survey of stereotactic ablative body radiotherapy in the UK by the QA group on behalf of the UK SABR ConsortiumVideo-assisted radiofrequency ablation for pleural disseminated non-small cell lung cancer.Alternative to surgery in early stage NSCLC-interventional radiologic approaches.Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm.Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer.Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas.Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology.Dosimetric evaluation of the feasibility of stereotactic body radiotherapy for primary lung cancer with lobe-specific selective elective nodal irradiationRadiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to knowImpact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smallerNew techniques for assessing response after hypofractionated radiotherapy for lung cancerOutcomes of lobectomy in patients with severely compromised lung function (predicted postoperative diffusing capacity of the lung for carbon monoxide % ≤ 40%).Managing lung cancer in high-risk patients: what to consider.Novel treatment options in stage I non-small-cell lung cancer.Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller.A Clinicopathological Study of Small Lung Adenocarcinoma 1 cm or Less in Size: Emphasis on Histological Subtypes Associated With Lymph Node Metastasis and Recurrence.Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.The Utility of Exercise Testing in Patients with Lung Cancer.Incorporating Geriatric Medicine Providers into the Care of the Older Adult with Cancer.Early lung cancer detection by low-dose CT screening: therapeutic implications.Is there a role for the high-risk multidisciplinary team meeting in thoracic surgery?Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer-Specific Death in Squamous Cell Carcinoma.Detection of Recurrence Patterns After Wedge Resection for Early Stage Lung Cancer: Rationale for Radiologic Follow-Up.Preliminary comparison of the registration effect of 4D-CBCT and 3D-CBCT in image-guided radiotherapy of Stage IA non-small-cell lung cancer.Heart rate recovery and survival in patients undergoing stereotactic body radiotherapy for treatment of early-stage lung cancer.Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.Helical Therapy is Safe for Lung Stereotactic Body Radiation Therapy Despite Limitations in Achieving Sharp Dose Gradients.Treatment selection of early stage non-small cell lung cancer: the role of the patient in clinical decision making.Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.Competing risks and cancer-specific mortality: why it matters.Surgical resection for clinical-Stage I radiological pure-solid lung cancer that met the current high risk criteria.Therapeutic surgery without a definitive diagnosis can be an option in selected patients with suspected lung cancer.Sarcopenia is a predictor of outcomes after lobectomy.Prognosis of limited resection versus lobectomy in elderly patients with invasive lung adenocarcinoma with tumor size less than or equal to 2 cm.
P2860
Q26853124-79A57B0A-72D9-4195-8053-B7A2B82A973EQ27025455-DCCDD7E1-B8FA-409D-85DB-5D045974B01CQ28079625-722B29A7-5AA1-4D0C-B48C-EAB7FC5EF41AQ33787072-CAD93538-B470-4C37-9796-56C14AF65C71Q33811206-B73035B7-F3A0-4974-8689-310C83F2ACF5Q33823049-5AFFBA8C-6102-4049-BE19-12FCEAD51E1EQ34768714-09595840-FA71-4A3A-BFF1-24E454E899E9Q35200640-18478BD0-2166-4C1A-952C-9AFC8A8F3FBCQ35216037-A9946D22-9F11-4126-B9DB-DCF901683910Q35558808-935DB890-B92F-4E16-9FD8-171552CE141EQ35845212-A87EDF58-87BC-4DFD-97DF-FCE77F0D66E5Q35954585-BEA05265-6D5F-4828-BC19-81C589C1ED19Q36162516-C371C1A5-675D-4BE8-A92A-0FFF8F0BF5DAQ36451644-3BE7B650-1869-414F-9F3E-6C365570D4E7Q36743276-0C908092-7A85-4B1F-9201-383826FE610AQ37106790-710DC216-D6A9-4C80-A804-C2DE8D2CECCCQ37670432-9843442C-6387-4879-B87F-763FFF6DB716Q38135436-EE905121-46B8-48CF-8C85-DC75AA1E939BQ38218238-6FFD8EC0-6DBF-4672-AD3F-5F2A5CACAA42Q38220335-BD4BEABB-BF0A-403E-9E1B-37B72158F6B2Q38240581-8CA412A9-08B2-4D9F-9977-23C5CFEC63D1Q38626380-1FF9A960-5595-4A3D-948E-10770CA1AE37Q38705115-C26BF4B2-19C4-4F4C-A4EA-83C786434E47Q38828542-D4AA11E9-1DA9-4CCA-97F5-9AF433824412Q38950570-3275BFFE-A275-49C6-B7DA-0FBC9CAF10FCQ39049280-14AE41CD-AA3A-4CD4-9469-36DBAF13A4DEQ40061623-DF87B502-11FA-47B9-8C62-5FE2042C5238Q40557873-F5E247FD-D36D-4D1E-B4CB-42415102DC67Q40681590-BB8BB31D-9BEC-46C6-A523-2F3BB007396CQ47110081-9C1EACD6-1241-4A8C-83AF-22D8F18984D9Q47142210-20B9DAE9-2958-4B5F-BDAF-A707A556B0C2Q48369218-3419786B-86BC-49E2-AED4-AE07F2C44641Q49244538-A11972A0-EF1A-4F2E-A10B-19D43DC24077Q50044375-3AB671C1-3177-495B-90D0-D37CCFA66C12Q51072077-B4830780-449A-47D5-9323-924C1B3FD47DQ52684158-16CCC5CA-B366-4F8C-BF2D-51A82C365656Q52879860-1FAADB0F-3E32-4CB9-9B4E-1BCFB29B3B40Q53059530-A85644D9-3A39-4AB5-9775-4B0C8FC052F7Q55025340-BB3CDF06-8095-4A5A-B8D1-99BDBAE0FF89Q55147993-AA16E73C-1C3F-41D9-939D-03CD74276DA7
P2860
American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
American College of Chest Phys ...... I non-small cell lung cancer.
@en
type
label
American College of Chest Phys ...... I non-small cell lung cancer.
@en
prefLabel
American College of Chest Phys ...... I non-small cell lung cancer.
@en
P2093
P356
P1433
P1476
American College of Chest Phys ...... e I non-small cell lung cancer
@en
P2093
Alberto de Hoyos
Arjun Pennathur
Frank Detterbeck
Gerard Silvestri
Jessica Donington
John Handy
John Howington
Mark Ferguson
Matthew Schuchert
P304
P356
10.1378/CHEST.12-0790
P407
P577
2012-12-01T00:00:00Z